Reading Practice 3 — AI in Healthcare

Artificial Intelligence in Modern Healthcare

PARAGRAPH A
Artificial intelligence is no longer a distant prospect for the healthcare sector — it is already reshaping how diseases are diagnosed, how treatments are planned, and how patient data is managed. From machine learning algorithms that detect tumours in medical scans to natural language processing tools that summarise clinical notes, AI applications in medicine are expanding at a remarkable pace. Proponents argue that these technologies will fundamentally improve patient outcomes and reduce the burden on overstretched health systems worldwide.

PARAGRAPH B
One of the most celebrated applications of AI in healthcare is medical imaging analysis. Deep learning models trained on millions of labelled scans have demonstrated diagnostic accuracy that rivals — and in some cases surpasses — that of experienced specialists. A landmark 2020 study found that an AI system could detect breast cancer in mammograms with a 5.7% reduction in false positives and an 11.5% reduction in false negatives compared to the standard two-reader human system. Such results have prompted regulatory bodies in several countries to approve AI-assisted screening tools for clinical use.

PARAGRAPH C
Beyond imaging, AI is being deployed in drug discovery, a process historically characterised by enormous cost and high failure rates. Traditional drug development can take over a decade and cost billions of dollars, with the majority of candidate compounds failing in clinical trials. Machine learning models can now analyse vast libraries of molecular data to predict which compounds are most likely to succeed, dramatically accelerating the early stages of development. The COVID-19 pandemic demonstrated this potential when AI tools helped identify promising antiviral candidates within weeks rather than years.

PARAGRAPH D
Despite these advances, significant concerns accompany the integration of AI into clinical settings. Chief among them is the issue of algorithmic bias. AI systems are only as reliable as the data on which they are trained, and if training datasets predominantly reflect certain demographic groups — as has historically been the case with medical research — the resulting algorithms may perform less accurately for underrepresented populations. Studies have shown that some AI diagnostic tools perform notably worse for patients of certain ethnicities, potentially exacerbating existing health inequalities rather than reducing them.

PARAGRAPH E
Another challenge involves accountability and transparency. When an AI system contributes to a misdiagnosis or a flawed treatment recommendation, determining responsibility is complex. Is the liability borne by the clinician who followed the AI's output, the developer who created the algorithm, or the hospital that deployed it? Current legal and regulatory frameworks were not designed with AI in mind, and there is an urgent need for updated governance structures that clearly delineate responsibility and establish minimum standards for AI validation and post-market surveillance.

PARAGRAPH F
Looking forward, the consensus among healthcare experts is that AI will function best not as a replacement for human clinicians but as a powerful augmentation tool. The most promising model is one of collaborative intelligence, where AI handles the processing of large datasets and the detection of subtle patterns, while clinicians apply contextual judgement, ethical reasoning, and patient communication — tasks that remain beyond the reach of current algorithms. Rather than displacing the medical profession, thoughtfully implemented AI may ultimately allow doctors to practise more humanely, spending less time on administrative tasks and more on direct patient care.